Literature DB >> 21560844

Epidemiology, risk factors, and overall survival rate of laryngeal cancer in Songklanagarind Hospital.

Tanadech Dechaphunkul1.   

Abstract

OBJECTIVE: To study epidemiology, risk factors and overall survival rate of patients with laryngeal cancer. MATERIAL AND
METHOD: A chart review of the patients diagnosed with laryngeal cancer in Songklanagarind Hospital over the past 10 years was performed.
RESULTS: Two hundred eighty nine patient cases were reviewed, in which 106 patients were diagnosed with supraglottic cancer 180 with glottic cancer and three with subglottic cancer. The majority of the patients was male, active smokers, alcohol consumers and had a histology showing squamous cell carcinoma. Disease characteristics indicated that most cases of supraglottic cancer were in a locally advanced stage (84.4%), whereas most patients with glottic cancer were diagnosed with early stage (61.3%). Hoarseness was the most common presenting symptom. Regarding the complete response rate, glottic cancer was superior to supraglottic cancer. For glottic cancer treatments, surgery alone or primary radiation showed good 5-year overall survival rates with no difference in modality results (87.5% versus 83.2%). In supraglottic cancer treatments and contrary to glottic cancer surgery with postoperative radiation improved the 5-year overall survival rate in comparison with primary radiation alone (52.2% versus 39.2%).
CONCLUSION: Primary radiation or surgery alone is suitable treatments for early stage laryngeal cancer especially in glottic cancer whereas surgery with postoperative radiation should be the treatment for advanced stage laryngeal cancer.

Entities:  

Mesh:

Year:  2011        PMID: 21560844

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  5 in total

1.  Laryngeal cancer survival in Zaragoza (Spain): a population-based study.

Authors:  Dyego Leandro Bezerra de Souza; Javier Jerez Roig; María Milagros Bernal
Journal:  Clin Transl Oncol       Date:  2012-03       Impact factor: 3.405

2.  Clinicopathologic Findings and Treatment Outcome of Laryngectomized Patients with Laryngeal Cancer and Hypopharyngeal Cancer: An Experience in Thailand

Authors:  Noppadol Larbcharoensub; Duangkamon Wattanatranon; Juvady Leopairut; Suwimon Suntisuktana; Boonsam Roongpupaht; Chalermchai Chintrakarn; Jumroon Tungkeeratichai; Phurich Praneetvatakul; Thongchai Bhongmakapat; Wichit Cheewaruangroj; Supawadee Prakunhungsit
Journal:  Asian Pac J Cancer Prev       Date:  2017-08-27

3.  Seeking Medical Assistance for Dysphonia Is Associated with an Improved Survival Rate in Laryngeal Cancer: Real-World Evidence.

Authors:  Yi-An Lu; Ming-Shao Tsai; Li-Ang Lee; Shu-Ru Lee; Li-Yun Lin; Chain-Fen Chang; Wan-Ni Lin; Li-Jen Hsin; Chun-Ta Liao; Hsueh-Yu Li; Yu-Wen Wen; Tuan-Jen Fang
Journal:  Diagnostics (Basel)       Date:  2021-02-07

4.  Lentivirus‑delivered nemo‑like kinase small interfering RNA inhibits laryngeal cancer cell proliferation in vitro.

Authors:  Jun Tai; Yuansheng Rao; Jugao Fang; Zhigang Huang; Zhenkun Yu; Xiaohong Chen; Weiguo Zhou; Xiao Xiao; Ting Long; Yang Han; Qiaoyin Liu; Aidong Li; Xin Ni
Journal:  Mol Med Rep       Date:  2015-08-06       Impact factor: 2.952

5.  An Overview of Laryngeal Cancer Treatment at a Tertiary Care Oncological Center in a Developing Country.

Authors:  Mohammad Adeel; Muhammad Faisal; Asma Rashid; Sadaf Usman; Usman Khaleeq; Taskheer Abbas; Abdul Rehman; Kashif Malik; Raza Hussain; Arif Jamshed
Journal:  Cureus       Date:  2018-06-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.